DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation
To the Company's knowledge, no proceedings have been initiated against theCompany at this time, although the Company cannot predict whether or whenproceedings might be initiated. The Company intends to cooperate with thegovernment's investigation.
"DaVita has been involved in several investigations over the last 9 years,including some covering issues that are repeated in this subpoena. We respectthe government's need to ensure the appropriateness of healthcare providerpractices, especially during times when pharmaceutical issues involvesignificant expense for Medicare. We look forward to meeting with governmentrepresentatives on this new investigation and once again demonstrating thestrength of our clinical outcomes and the integrity and comprehensiveness ofDaVita's Compliance programs," said LeAnne Zumwalt, spokesperson for DaVita.
DaVita is a leading provider of kidney care in the United States,providing dialysis services and education for patients with chronic kidneyfailure and end stage renal disease. DaVita manages more than 1,400 outpatientfacilities and acute units in more than 700 hospitals located in 43 states andthe District of Columbia, serving approximately 110,000 patients.
SOURCE DaVita Inc.
You May Also Like